Remodelling of immune system by TB vaccine may explain its link with lower Alzheimer's risk: Study

A study published in Communications Medicine suggests that the BCG tuberculosis vaccine may help reduce Alzheimer's disease risk by reprogramming the brain's immune cells. Researchers observed that the vaccine promotes 'trained immunity,' which can modify Alzheimer's-related biomarkers in older adults.
The remodelling of the human brain's immune environment by the tuberculosis vaccine BCG could offer a potential biological explanation for previously observed links between the vaccine and lower Alzheimer's disease risk, according to a study.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in